|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 125, Issue 3 533-544, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
P Ruiz-Lozano, SM Smith, G Perkins, SW Kubalak, GR Boss, HM Sucov, RM Evans and KR Chien
Department of Medicine and Center for Molecular Genetics, University of California, San Diego, La Jolla 92093, USA.
RXRalpha null mutant mice display ocular and cardiac malformations, liver developmental delay, and die from cardiac failure around embryonic day (E) 14.5 pc. To dissect the molecular basis of the RXRalpha-associated cardiomyopathy, we performed subtractive hybridization and systematically characterized putative downstream target genes that were selectively lacking in the mutant embryos, both at early (E10.5) and late (E13.5) stages of mouse embryonic development. Approximately 50% of the subtracted clones (61/115) encoded proteins involved in intermediary metabolism and electron transport, suggesting an energy deficiency in the RXRalpha-/- embryos. In particular, clone G1, which encodes subunit 14.5b of the NADH-ubiquinone dehydrogenase complex, displayed a dose-dependent expression in the wild-type, heterozygous and RXRalpha mutant mice. This gene was also downregulated in a retinoid-deficient rat embryo model. ATP content and medium Acyl-CoA dehydrogenase mRNA were lower in RXRalpha mutant hearts compared to wild-type mice. Ultrastructural studies showed that the density of mitochondria per myocyte was higher in the RXRalpha mutant compared to wild-type littermates. We propose a model whereby defects in intermediary metabolism may be a causative factor of the RXRalpha-/- phenotype and resembles an embryonic form of dilated cardiomyopathy.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  P. F. van Loo, E. A. F. Mahtab, L. J. Wisse, J. Hou, F. Grosveld, G. Suske, S. Philipsen, and A. C. Gittenberger-de Groot Transcription Factor Sp3 Knockout Mice Display Serious Cardiac Malformations Mol. Cell. Biol., December 15, 2007; 27(24): 8571 - 8582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Berdanier Mitochondrial gene expression: influence of nutrients and hormones. Experimental Biology and Medicine, November 1, 2006; 231(10): 1593 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Merki, M. Zamora, A. Raya, Y. Kawakami, J. Wang, X. Zhang, J. Burch, S. W. Kubalak, P. Kaliman, J. C. I. Belmonte, et al. From the Cover: Epicardial retinoid X receptor {alpha} is required for myocardial growth and coronary artery formation PNAS, December 20, 2005; 102(51): 18455 - 18460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kaliman, D. Catalucci, J. T. Lam, R. Kondo, J. C. P. Gutierrez, S. Reddy, M. Palacin, A. Zorzano, K. R. Chien, and P. Ruiz-Lozano Myotonic Dystrophy Protein Kinase Phosphorylates Phospholamban and Regulates Calcium Uptake in Cardiomyocyte Sarcoplasmic Reticulum J. Biol. Chem., March 4, 2005; 280(9): 8016 - 8021. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. CASAS, L. DAURY, S. GRANDEMANGE, M. BUSSON, P. SEYER, R. HATIER, A. CARAZO, G. CABELLO, and C. WRUTNIAK-CABELLO Endocrine regulation of mitochondrial activity: involvement of truncated RXR{alpha} and c-Erb A{alpha}1 proteins FASEB J, March 1, 2003; 17(3): 426 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Osorio, W. C. Stanley, A. Linke, M. Castellari, Q. N. Diep, A. R. Panchal, T. H. Hintze, G. D. Lopaschuk, and F. A. Recchia Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-{alpha} in Pacing-Induced Heart Failure Circulation, July 30, 2002; 106(5): 606 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Marin-Garcia and M. J. Goldenthal Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis Cardiovasc Res, June 1, 2002; 54(3): 516 - 527. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Faiella, M. Wernig, G. G. Consalez, U. Hostick, C. Hofmann, E. Hustert, E. Boncinelli, R. Balling, and J. H. Nadeau A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression Hum. Mol. Genet., January 22, 2000; 9(2): 227 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Hertig, S. W. Kubalak, Y. Wang, and K. R. Chien Synergistic Roles of Neuregulin-1 and Insulin-like Growth Factor-I in Activation of the Phosphatidylinositol 3-Kinase Pathway and Cardiac Chamber Morphogenesis J. Biol. Chem., December 24, 1999; 274(52): 37362 - 37369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Giguère Orphan Nuclear Receptors: From Gene to Function Endocr. Rev., October 1, 1999; 20(5): 689 - 725. [Abstract] [Full Text]
|
|
|
|
|
|
Q. Zhou, P. Ruiz-Lozano, M. E. Martone, and J. Chen Cypher, a Striated Muscle-restricted PDZ and LIM Domain-containing Protein, Binds to alpha -Actinin-2 and Protein Kinase C J. Biol. Chem., July 9, 1999; 274(28): 19807 - 19813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gruber, S. Kubalak, and K. Chien Downregulation of atrial markers during cardiac chamber morphogenesis is irreversible in murine embryos Development, January 11, 1998; 125(22): 4427 - 4438. [Abstract] [PDF]
|
|
